Quick Overview: Welcome back to another episoe of The Bio Hub, we were delighted to be joined by Dr. Primary hyperoxaluria type 1 – PH1 – pushes more than 70% of patients into end-stage kidney disease, often before they finish ... Gene editing is creating curative therapies for patients that can completely change the trajectory of healthcare. In this ARM Studios ...
Devyn Smith Ceo Arbor Biotechnologies - Detailed Overview & Context
Welcome back to another episoe of The Bio Hub, we were delighted to be joined by Dr. Primary hyperoxaluria type 1 – PH1 – pushes more than 70% of patients into end-stage kidney disease, often before they finish ... Gene editing is creating curative therapies for patients that can completely change the trajectory of healthcare. In this ARM Studios ... Gene editing and cell therapy, they're going to be entrenched modalities, much like small molecules and antibodies are today, ... In this episode of The BioHub Podcast, Max sits down with Amin Zargar, What does a career look like when one chapter ends with an $11 billion acquisition, the next involves FBI visits and death threats, ...
Dr. Andrew Snyder (Monash University) joins the show to discuss the current Michael Penn, PhD, discusses Genentech's approach to Business Development and highlights the project lifecycle for ...
